Ashp Bcps Study Guide 2015
ASHP offers board review and recertification programs for Ambulatory Care Pharmacy, Critical Care Pharmacy, Geriatric Pharmacy, Oncology Pharmacy, Pediatric Pharmacy and Pharmacotherapy. Interdisciplinary Journal of Problem-Based Learning. 2015; 9:58-72. Describe the rationale, methodology, and limitations of the study validating the Active Learning in Health Professionals Scale (ALHPS) Discuss the findings from the study validating the Active Learning in Health Professionals Scale (ALHPS) Mitchell A, Petter S, Harris AL.
Held annually at The Midyear, the Intensive Study Package provides 6 hours of BPS approved recertification credit through a high-level, interactive discussion on contemporary and emerging issues in pharmacotherapy. These activities are approved by the Board of Pharmacy Specialties (BPS) and/or the Commission for Certification in Geriatric Pharmacy (CCGP). For pharmacists who maintain more than one certification, some of these sessions provide credit for more than one specialty. Up to six hours of recertification credit may be earned for each specialty New Format! This year the sessions will be held live throughout the Midyear and any meeting registrant may attend these thought-provoking and highly educational sessions. However, if you are BCPS certified, you must purchase the package to receive the recertification test and to claim the credit. How to participate.
You must be a full time Midyear registrant to receive recertification credit for the designated sessions. During the Midyear registration process, add on the desired recertification package (BCPS, BCACP, CGP). To an existing Midyear registration. Attend the live sessions at the ASHP Midyear Clinical Meeting, December 6-10 in New Orleans. Unable to attend all of the sessions at Midyear?
Ashp Bcps Study Guide
The recertification package also provides online access to all of the sessions in your selected specialty. After Midyear, complete and pass the recertification assessments for the desired sessions. Each session provides 2 hours of credit. Up to 6 hours may be earned for each specialty.
Gmc sierra manual shop. The assessments will be available online in February 2016. You will receive an email with instructions on how to access your recorded sessions and recertification test. Dual or triple certified?
Passing a recertification assessment for a session with multiple certifications will provide you hours for each of your specialties. For example, by passing the assessment for the Diabetes activity, you earn hours toward BCPS, BCACP, and CGP.
Sessions with multiple certification available are noted below. Pricing The price for 6 hours of recertification credit for the Live Intensive Study Package is $50 for Midyear attendees. This includes the live sessions, the recorded sessions, and the recertification test. Monday, December 7, 2015 Time: 2:00 p.m. Individualizing Therapy for Patients with Type 2 Diabetes ACPE Activity #: 0204-9999-15-237-L01-P Level of Content: Advanced Contact Hour(s): 2.0 / Application-based Recertification Credit for: BCPS, BCACP, CGP The goal of this 2-hour session is to develop the participant ability to appropriately individualize management of type 2 diabetic patients utilizing combinations of oral anti-diabetic agents or combinations of oral anti-diabetic agents with insulin. Participants will be presented with case-based questions.
Following audience response, the faculty will discuss the correct answer and rationale based on applicable evidence-based medicine. Target Audience Board-certified and other advanced level pharmacists who manage and recommend drug therapy for type 2 diabetic patients in preparation for hospital discharge, in the ambulatory care setting, or in a long term care facility.
This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP), Board Certified Pharmacotherapy Specialist (BCPS), and Certified Geriatric Pharmacist (CGP) recertification credit. Learning Objectives.
Discuss specific effects of anti-diabetic agents on pathophysiologic deficits. Evaluate patients who may benefit from individualized therapy, including specific populations. Recommend appropriate use of anti-diabetic therapy based on evidence-based medicine and national guidelines. Compare and contrast optimal anti-diabetic therapy for different adult age groups. Faculty Kristi W. Kelley, Pharm.D., BCPS, CDE, BC-ADM, Program Chair Associate Clinical Professor- Auburn University Harrison School of Pharmacy Clinical Pharmacist-Baptist Health, Inc. Birmingham, Alabama Melody Hartzler, Pharm.D., AE-C, BCACP Assistant Professor of Pharmacy Practice- Cedarville University School of Pharmacy Cedarville, Ohio.
Tuesday, December 8, 2015 Time: 9:00 a.m. Making Sense of Infectious Diseases Clinical Practice Guidelines ACPE Activity #: 0204-0000-15-291-L01-P Level of Content: Advanced Contact Hour(s): 2.0 / Application-based Recertification Credit for: BCPS Description: This session will focus on practice guidelines in infectious diseases, including limitations of the guideline development process. Participants will be challenged with audience response cases that will illustrate controversies and shortcomings of particular guidelines. Target Audience Board-certified and other advanced level pharmacists who manage and recommend antimicrobial therapy. This activity is approved for Board Certified Pharmacotherapy Specialist (BCPS) recertification credit.
Learning Objectives. Identify examples of practice changes that resulted from guidelines. Critically evaluate guidelines for selected infectious diseases for relevance and applicability to current practice. Describe how selected infectious diseases guidelines should be applied in clinical practice and the areas in which they are likely to evolve.
Faculty Douglas Slain, Pharm.D., BCPS, FASHP, Program Chair Associate Professor & Clinical Specialist West Virginia University Morgantown, West Virginia Jason Gallagher, Pharm.D., BCPS, FCCP Clinical Professor Temple University Philadelphia, Pennsylvania P. Brandon Bookstaver, Pharm.D., BCPS (AQ-ID), FCCP Associate Professor & Vice Chair University of South Carolina Columbia, South Carolina Time: 2:00 p.m. Does Practice Need to a-DAPT? Considerations in Antiplatelet Therapy after Drug-Eluting Stent Implantation ACPE Activity #: 0204-9999-15-292-L01-P Level of Content: Advanced Contact Hour(s): 2.0 / Application-based Recertification Credit for: BCPS, BCACP Each year over 700,000 Americans suffer from a myocardial infarction. Many of these patients receive drug-eluting stents via percutaneous intervention. In order to reduce in-stent thrombosis, dual antiplatelet therapy (DAPT) is given for 6-12 months as the standard of care.
Ashp Bcps Study Schedule
However, recent trials have raised questions on the proper length of time to utilize DAPT in patients implanted with drug-eluting stents. Therefore, in this interactive session, the faculty will critically evaluate the current literature while utilizing case-based questions and group discussion to determine the most appropriate length of time to treat patients with dual antiplatelet therapy. Target Audience Board-certified and other advanced level pharmacists who manage and recommend anticoagulation therapy for patients with cardiovascular disease. This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Pharmacotherapy Specialist (BCPS) recertification credit.
Learning Objectives. Discuss the current guideline recommendations for using dual antiplatelet therapy following drug-eluting stent implantation.
Interpret the clinical trial evidence that supports the use of DAPT for one year. Evaluate the clinical trial evidence that refutes the use of DAPT for one year. Design an evidence based DAPT regimen in a complex patient following drug-eluting stent implantation. Faculty Christopher Betz, Pharm.D., BCPS, FKSHP, FASHP, Program Chair Professor- Sullivan University College of Pharmacy Louisville, Kentucky Snehal Bhatt, Pharm.D., BCPS Associate Professor of Pharmacy Practice- Massachusetts College of Pharmacy and Health Sciences University Clinical Pharmacist- Beth Israel Deaconess Medical Center Boston, Massachusetts Accreditation for Pharmacists The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.